ImpriMed Inc: Valuation, Funding & Investors
ImpriMed, Inc. is a precision medicine company developing AI-driven drug response prediction technologies for cancer care. Its platform analyzes patient and tumor characteristics to help veterinarians and clinicians identify potentially effective treatments, reduce unnecessary costs, accelerate therapy decisions, and improve outcomes in canine, feline, and human oncology.
Leadership & Board
- Current Number of Employees
- 45
- Current LinkedIn Followers
- 5,907
Latest Estimated Valuation
- Total Amount Raised
- $10M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $10M
- Latest Funding Round
- Series A
Company Momentum
PositiveImpriMed Inc LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
ImpriMed Inc had 45 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
ImpriMed Inc had 5,907 followers as of November 16, 2026. The number of followers increased by 7 (0.12%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 24, 2026 | Series A | $10.00M | ― |
Similar Companies
A snapshot of private companies similar to ImpriMed Inc, helping you discover and navigate related company profiles.
Related News and Analysis









